Gains in Employment Status Are Associated With Lower Methamphetamine Use Frequency at Outpatient Specialty Treatment Discharge [0.03%]
就业状况的改善与门诊专科治疗出院时较低的甲基苯丙胺使用频率相关
Nicholas L Bormann,Tyler S Oesterle,Andrea N Weber et al.
Nicholas L Bormann et al.
Objectives: Employment can provide structure and economic opportunity. We examined whether changes in employment status from treatment admission to discharge co-occurred with changes in methamphetamine use frequency over ...
Estimated Prevalence of Current Posttraumatic Stress Disorder Among Pregnant Women With Opioid Use Disorder-MATernaL and Infant Clinical NetworK (MAT-LINK), 2014-2021 [0.03%]
2014-2021年美国 MATernal和婴幼儿临床网络(MAT-LINK)中妊娠合并阿片类药物使用障碍的当前创伤后应激障碍患病率估算
Kelly R Peck,Min-Hsuan Chen,Brianna Lee et al.
Kelly R Peck et al.
Objectives: Posttraumatic stress disorder (PTSD) during pregnancy is associated with adverse consequences and has an estimated prevalence of 3% in community samples. The prevalence of current PTSD among pregnant women wit...
When a Withdrawal Aid Mimics a Brainstem Lesion: Gabapentin-associated Transient Ophthalmoplegia [0.03%]
一种撤药反应模拟脑干病变：加巴喷丁相关性短暂眼肌麻痹
Maryam Soltani
Maryam Soltani
Objectives: Gabapentin is frequently used as a benzodiazepine-sparing agent for the management of mild to moderate alcohol withdrawal and is generally considered well-tolerated. Although neurological adverse effects have ...
Treatment of Kratom Use Disorder With Methadone in an Opioid Treatment Program [0.03%]
含甲基安非他命治疗项目中 kratom使用障碍的治疗
Robert C Sherrick
Robert C Sherrick
Background: Kratom (Mitragyna speciosa) and its active alkaloids, mitragynine and 7-hydroxymitragynine, can produce opioid-like dependence and withdrawal meeting DSM-5 criteria for opioid use disorder (OUD). While bupreno...
Xylazine Exposure and Association With Early Physiological and Withdrawal Symptoms in People With Opioid Use Disorder [0.03%]
美沙酮维持治疗患者卡马西平暴露与早期生理及戒断症状的关系
Justin C Strickland,Cecilia L Bergeria,Andrew S Huhn et al.
Justin C Strickland et al.
Objectives: The prevalence of xylazine, an agonist at the alpha-2 adrenergic receptor often used in veterinary medicine, has increased in the illicit opioid drug supply. Case series and survey data suggest that xylazine m...
Opioid Use Disorder Care Presentations After High-deductible Health Plan Enrollment [0.03%]
高自付额健康计划的参保者接受阿片类药物使用障碍治疗的情况
Bryant Shuey,Fang Zhang,Stephanie Argetsinger et al.
Bryant Shuey et al.
Objective: Determine whether employer-mandated transitions from low- to high-deductible health plans (HDHPs) are associated with delays in opioid use disorder (OUD)-related care presentations. Cost-sharing may negatively ...
Medetomidine-Involved Overdoses Among Emergency Department Patients: Results From a US Multicenter Sentinel Surveillance Program [0.03%]
美国多中心哨点监测计划中的急诊患者阿片类药物过量事件：伴用美达托密啶的影响
Andrew Stolbach,Rachel Culbreth,Alyssa Falise et al.
Andrew Stolbach et al.
Objectives: Medetomidine is an alpha-2 adrenoreceptor agonist approved only for veterinary sedation and was reported in the US illicit drug supply starting in 2022. Our aim was to determine the prevalence of medetomidine ...
Antecedents of Fentanyl Coinvolvement in Deaths Attributed to Stimulant Poisoning in San Francisco, CA [0.03%]
芬太尼涉入加利福尼亚州旧金山地区刺激毒物中毒死亡的前兆研究
Yi-Shin Grace Chang,Vanessa M McMahan,Luke N Rodda et al.
Yi-Shin Grace Chang et al.
Objectives: Deaths attributed to stimulants in the United States are largely driven by fentanyl coinvolvement. We sought to compare antecedents of acute stimulant deaths involving fentanyl to those that do not involve opi...
Kaitlyn Kasemodel,Spencer Ilstrup,Jaymie Avenido et al.
Kaitlyn Kasemodel et al.
Xylazine, an alpha-2 adrenergic agonist veterinary sedative, has emerged as a frequent adulterant in illicit opioids, contributing to the ongoing "tranq dope" crisis. Its effects on human pregnancy are largely unknown, posing new challenges...
Hospitalizations and Mortality Following Skilled Nursing Facility Admission by Opioid Use Disorder Status [0.03%]
根据是否患有阿片类药物使用障碍住院和入住 skilled nursing facility 后的死亡率
Patience M Dow,Miriam George,Andrew R Zullo et al.
Patience M Dow et al.
Objectives: Prior studies have documented rising rates of referrals to skilled nursing facilities (SNFs) for hospitalized patients with opioid use disorder (OUD). However, the care transitions and survival of people with ...